Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021Esther Kissling, Lisa Domegan, Simon de Lusignan et al.|Eurosurveillance|2021Cited by 55
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022Angela Rose, Patricia Bruijning‐Verhagen, Nathalie Nicolay et al.|Eurosurveillance|2023Cited by 18
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Rose, Regina Demlová, Nathalie Nicolay et al.|Eurosurveillance|2023Cited by 4
Vaccine effectiveness against hospitalisation with COVID-19 prior to and during Delta circulation in Europe in adults aged 30 yrs and over: I-MOVE-COVID-19 and ECDC hospital networks, JanuaryDecember 2021Angela Rose, Sabrina Bacci, Nathalie Nicolay et al.|Lithuanian University of Health Sciences|2022Cited by 0